CTT Pharma discusses patent coverage for pets

Tampa, Florida, United States – TheNewswire – May 9, 2022 – CTT Pharmaceutical Holdings Inc. CTTH recent patent in the United States as well as our Canadian patents, patents pending in Europe and many other patents issued and pending around the world cover CTT’s dissolvable strips for pets, especially for dogs and cats. CBD, CBG, CBN, Vitamins and even pet medicines can be used with our technology and are protected with our patents. In addition, we can freshen the breath of pets while giving them different uses for our dissolvable strips. The benefits of our pet strips are many. CTT Pet Strips dissolve quickly, reducing the potential for expansion, providing better absorption/bioavailability, a rapid onset as fast as an injection, enters the bloodstream through the stomach and is easy to administer.

CBG has been found to have anti-inflammatory and antioxidant properties, making it potentially beneficial for conditions in dogs such as arthritis and hip dysplasia. Mood Enhancement: CBG May Help Dogs With Anxiety. While CBD is also used for its anti-inflammatory properties, heart benefits, anti-nausea effects, appetite stimulant, anti-anxiety effect, and CBN has been shown to help with restlessness and promote a calming effect for pets.

CTT’S patents also cover vitamins, drugs and other actives, which can be used in combination with CBG, CBD and CBN.

I believe it is important for our shareholders, potential customers and customers to understand that there is a global pet strip market available and covered by our patents. I look forward to discussing these opportunities further with potential pet companies looking to bring our innovative technology to market, said Ryan Khouri, CEO of CTT Pharma.

CTT Pharma will continue to inform our shareholders as more news becomes available.

Ryan Khouri – 813-606-0060



Copyright (c) 2022 TheNewswire – All rights reserved.

This post CTT Pharma discusses patent coverage for pets was original published at “https://www.benzinga.com/markets/penny-stocks/22/05/27206565/ctt-pharma-discusses-patent-coverage-for-pets”

Leave a Reply

Your email address will not be published.